Lanashield Skin Barrier — Class II drug recall D-0201-2026
Ongoing recall by Blossom Pharmaceuticals, reported 2025-12-10, distributed nationwide. cGMP deviations
| Recall number | D-0201-2026 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Blossom Pharmaceuticals, Bardej, Goa, India |
| Recall initiated | 2025-10-31 |
| Classified | 2025-12-02 |
| Reported by FDA | 2025-12-10 |
| Distributed | Nationwide (US) |
| Quantity | 9,600 containers |
| Reason classes | cgmp |
| UPC / GTIN / UDI-DI | 00616784126319 |
| Lot numbers | 11/25, 4/27, 9/26, A162202, A162301, A162401 |
Product
Lanashield Skin Barrier, 4 oz. (113 g), Manfuactured for: Dynarex Corporation, 10 Gleshaw Street, Orangeburg, NY 10962 USA, Made in India, UPC 616784126319.
Reason for recall
cGMP deviations
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0201-2026. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.